Sign In

Min Li

Chief Executive Officer at SciNeuro Pharmaceuticals

Min Li is a prominent figure in the field of neuromedicine, renowned for his role as the founder and CEO of SciNeuro Pharmaceuticals, a cutting-edge company focused on developing innovative treatments for CNS diseases.

With a rich and diverse background, Dr. Li has made significant contributions in academia, the pharmaceutical industry, and venture capital. He served as a Venture Partner at Lilly Asia Ventures and held senior leadership positions at GSK, a top multinational pharmaceutical company.

Prior to his corporate endeavors, Dr. Li was a distinguished Professor of Neuroscience at Johns Hopkins University School of Medicine, a renowned institution in the medical field. He holds a Ph.D. in Immunology from The Johns Hopkins University School of Medicine, showcasing his strong educational foundation.

Dr. Li's expertise is further enhanced by his Post-doctoral Fellowship in Neuroscience from the University of California, San Francisco, and a Bachelor of Science in Biochemistry from Wuhan University.

His illustrious career is bolstered by a remarkable publication and patent portfolio, consisting of over 100 works. Dr. Li's outstanding contributions have garnered him prestigious international awards and accolades, including recognition as a Fellow of the American Association for the Advancement of Science.

In addition to his entrepreneurial and scientific pursuits, Dr. Li has also held the position of Scientist at the AFFYMAX Research Institute. His seamless transition across various sectors underscores his adaptability and expertise in driving advancements in neuromedicine and healthcare.

Dr. Min Li's comprehensive experience, academic achievements, and leadership roles position him as a key influencer in the field of CNS diseases and pharmaceutical innovation, making him a highly respected figure in the global healthcare landscape.

Min Li
Add to my network

Location

Rockville, Maryland, United States